Cornerstone Planning Group LLC Royalty Pharma PLC Transaction History
Cornerstone Planning Group LLC
- $418 Billion
- Q1 2025
A detailed history of Cornerstone Planning Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 100 shares of RPRX stock, worth $3,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 47
112.77%
Holding current value
$3,486
Previous $1.49 Million
112.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.43 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$802 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$467 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$424 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...